heart transplantation

Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in a Pediatric Patient With Cardiac Allograft Vasculopathy

10/27/2014

Rigved V. Tadwalkar, MD, MS and Michael S. Lee, MD

Rigved V. Tadwalkar, MD, MS and Micha...

Cardiac allograft vasculopathy (CAV) is an immunologically-mediated phenomenon that occurs in up to 50% of patients surviving to 10 years post orthotopic heart transplant. While the pediatric subgroup of OHT recipients has a lower overall...

Cardiac allograft vasculopathy...

10/27/2014

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

heart transplantation

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products